Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Glassman

Showing results (211-220 of 229) with videos related to

Pageof 23
Sort By:
Ophthalmology. Retina|October 10, 2021
A Randomized Trial of Photobiomodulation Therapy for Center-Involved Diabetic Macular Edema with Good Visual Acuity (Protocol AE)Judy E Kim, Adam R Glassman, Kristin Josic, et al.
Translational Vision Science & Technology|December 30, 2021
Conversion of Central Subfield Thickness Measurements of Diabetic Macular Edema Across Cirrus and Spectralis Optical Coherence Tomography InstrumentsJennifer K Sun, Kristin Josic, Michele Melia, et al.
Texas Heart Institute Journal|April 16, 2015
Acute surgical pulmonary embolectomy: a 9-year retrospective analysisAlan R Hartman, Frank Manetta, Ronald Lessen, et al.
JAMA Ophthalmology|July 26, 2018
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical TrialJeffrey G Gross, Adam R Glassman, Danni Liu, et al.
Ophthalmology Science|May 1, 2026
Oral Tonabersat Connexin-43 Modulator for Diabetic Macular Edema with Good Vision (DRCR Retina Network Protocol AN)Andrew J Barkmeier, Thu P Vu, Michael Elman, et al.
American Journal of Ophthalmology|February 26, 2008
Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathyNeil M Bressler, Allison R Edwards, Andrew N Antoszyk, et al.
Elife|May 18, 2021
Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonistCaleb R Glassman, Leon Su, Sonia S Majri-Morrison, et al.
The New England Journal of Medicine|July 14, 2022
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular EdemaChirag D Jhaveri, Adam R Glassman, Frederick L Ferris, et al.
JAMA Ophthalmology|November 26, 2015
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular EdemaJohn A Wells, Adam R Glassman, Lee M Jampol, et al.
Ophthalmology|March 14, 2007
Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema, Magdalena G Krzystolik, Samara F Strauber, et al.
Pageof 23

Showing results (211-220 of 229) with videos related to

Sort By:
Pageof 23
Ophthalmology. Retina|October 10, 2021
A Randomized Trial of Photobiomodulation Therapy for Center-Involved Diabetic Macular Edema with Good Visual Acuity (Protocol AE)Judy E Kim, Adam R Glassman, Kristin Josic, et al.
Translational Vision Science & Technology|December 30, 2021
Conversion of Central Subfield Thickness Measurements of Diabetic Macular Edema Across Cirrus and Spectralis Optical Coherence Tomography InstrumentsJennifer K Sun, Kristin Josic, Michele Melia, et al.
Texas Heart Institute Journal|April 16, 2015
Acute surgical pulmonary embolectomy: a 9-year retrospective analysisAlan R Hartman, Frank Manetta, Ronald Lessen, et al.
JAMA Ophthalmology|July 26, 2018
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical TrialJeffrey G Gross, Adam R Glassman, Danni Liu, et al.
Ophthalmology Science|May 1, 2026
Oral Tonabersat Connexin-43 Modulator for Diabetic Macular Edema with Good Vision (DRCR Retina Network Protocol AN)Andrew J Barkmeier, Thu P Vu, Michael Elman, et al.
American Journal of Ophthalmology|February 26, 2008
Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathyNeil M Bressler, Allison R Edwards, Andrew N Antoszyk, et al.
Elife|May 18, 2021
Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonistCaleb R Glassman, Leon Su, Sonia S Majri-Morrison, et al.
The New England Journal of Medicine|July 14, 2022
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular EdemaChirag D Jhaveri, Adam R Glassman, Frederick L Ferris, et al.
JAMA Ophthalmology|November 26, 2015
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular EdemaJohn A Wells, Adam R Glassman, Lee M Jampol, et al.
Ophthalmology|March 14, 2007
Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema, Magdalena G Krzystolik, Samara F Strauber, et al.
Pageof 23